Scientific Advisors

Professor Michael (Monty) Mythen, MD, FRCA, Clinical Consultant

Smiths Medical Professor of Anaesthesia and Critical Care, UCL; Honorary Consultant Anaesthesia and Critical Care UCL Hospitals (UCLH) NHS Foundation Trust; Director, Centre for Anaesthesia UCL; Director of Research and Development UCLH NHS Foundation Trust; Director Joint UCLH/UCL Biomedical Research Unit; National Clinical Lead Enhanced Recovery Partnership Programme, UK Department of Health; Board Member of the Faculty of Intensive Care Medicine; Chair of the Intensive Care Foundation’s Scientific Advisory Board; Chair of the Improving Surgical Outcomes Group; Editorial board member for The British Journal of Anaesthesia, Critical Care; Co-Chairman Evidence Based Peri-operative Medicine (EBPOM) annual meeting and website; Board Member, National Institute Academic Anaesthesia; Examiner for European Diploma of Intensive Care Medicine.

Professor Michael (Monty) Mythen completed his UK anaesthesia fellowship (FRCA) in 1990, gained an MD in 1995 and was appointed assistant professor at Duke University Medical Centre, North Carolina, USA before returning to the UK.

He has a wide range of research interests including: peri-operative fluid management and trans-oesophageal Doppler, haemostasis in the critically ill, endotoxin and endotoxin immunity and the determinants of post-operative morbidity and mortality. He has over 100 publications on PubMed and has extensive editorial involvement with a number of anaesthetic and critical care journals. He recently took part in “Caudwell Xtreme Everest” and as project leader spent 3 months as the laboratory manager at The Smiths Medical High altitude laboratory, Namche, Nepal (3,500m).

Professor Vincent Lawton CBE, Chairman

Professor Vincent Lawton CBE was Managing Director and Vice President Europe of Merck Sharp and Dohme UK (MSD) Ltd with whom he worked for 26 years in senior positions across Europe and North America. Professor Lawton joined MSD in 1980 as Human Resources Director in Europe. In the United States he worked in the Research and Development and commercial areas. He worked in the Marketing Department in MSD Canada, launching a new treatment for urinary tract infection (UTI), achieving market leadership.

In 1987, he was the Pharmaceutical Division Director for MSD in Spain, where he successfully launched a number of major new products and helped to drive the company’s considerable success in the Spanish market. Professor Lawton’s last position was Managing Director of MSD UK and Vice President in Europe, where he made many personal achievements, including significant business growth between 1991 and 2006. He served on the Board of Management of the ABPI for 15 years. He was a founder member of Pharmaceutical Industry Competitiveness Task Force (PICTF), co Chairing the Clinical Research in the NHS Task force with Sir John Pattison and latterly with Professor Sally Davies. He was also a founder member of Ministerial Industry Strategy Group (MISG). During 2004 and 2006 he was President of the Association of the British Pharmaceutical Industry (ABPI) and was appointed CBE in the 2006 New Years Honours list for services to the pharmaceutical industry.